XRF Scientific (ASX: XRF) Reports Soft Earnings Growth In H1 FY 2026
Muted earnings per share growth saw the stock decline post results release.
XRF Scientific (ASX: XRF) specialises in machines that heat up mining samples, melt them down, and analyse the constituents. XRF Scientific makes money from selling products for the laboratory and industrial platinum alloy markets, selling capital equipment for testing, and selling the consumable products required to run the testing machines.
Muted earnings per share growth saw the stock decline post results release.
The September quarter was a bit weak but the outlook is positive and the thesis remains on track.
ASX Small Cap Wrap ep6: Claude Walker & Patrick Poke cover XRF, Monash IVF, Cuscal & PWR, sharing insights as ASX reporting season draws to a close.
The XRF Scientific share price has fallen about 4.2% today, on the release of its FY 2025 results, despite strong EPS growth of 15%.
Claude Walker and Andrew Page discuss Andrew’s latest 10-bagger, and a couple of prospective ASX small-cap stocks besides that.
I like each of these companies at current prices, and I already own them. But if the share prices fall due to macroeconomic volatility, there is a price at which I would probably buy more…
The Q3 results were a little on the weak side, but still very solid.
Solid results from a company that just keeps on delivering growth.
The company had a slightly weaker quarter, but it was just one quarter.
The company demonstrated everything I had hoped to see in this set of results, with earnings per share up 15%.
Albeit hardly thesis changing, there is some new information to consider regarding each of these stocks.
XRF Scientific (ASX: XRF) reported strong profit growth on modest revenue growth.
XRF Scientific (ASX: XRF) H1 FY 2023 Results shows a company firing on all cylinders, though it may be cyclical.
These 5 stocks each have strong share price momentum backed up by strong recent profit growth.